Jacquet’s Erosive Folliculitis

Overview

Jacquet’s erosive folliculitis (also called follicular erosion syndrome or Jacquet’s disease) is a chronic inflammatory condition that primarily affects the hair follicles of the scalp, face, neck, and occasionally other hair‑bearing skin. It is characterized by painless erosions or shallow ulcers that develop within inflamed hair follicles, often leaving a crusted or hyperpigmented scar after healing.

The disorder was first described by French dermatologist Alfred Jacquet in 1923. Although it is considered rare, the exact prevalence is unknown because many cases are misdiagnosed as acne, folliculitis decalvans, or other dermatologic conditions. A retrospective review of dermatology clinic records in France reported an incidence of approximately 0.5 cases per 100,000 persons per year in the adult population [1].

Jacquet’s erosive folliculitis most commonly appears in adolescents and young adults (15‑30 years) but can affect children and older adults. Both sexes are affected, with a slight male predominance (≈ 55 % of reported cases) [2].

Symptoms

The clinical picture can be subtle at first and then evolve. Key symptoms include:

• Follicular erosions or shallow ulcers – small, well‑demarcated pits (2‑5 mm) that may exude a clear or serous fluid.
• Crust formation – a yellow‑white or honey‑colored crust appears after the fluid dries.
• Hyperpigmented or atrophic scars – healing often leaves a noticeable brownish patch or slight indentation.
• Itch or mild burning sensation – usually less intense than in acute bacterial folliculitis.
• Absence of purulent drainage – differentiates it from bacterial infections.
• Distribution pattern – most frequently on the scalp, forehead, upper chest, back, and occasionally the axillae.
• Hair loss in affected areas – when the follicle is damaged, mild alopecia can occur.

Systemic symptoms such as fever, chills, or malaise are generally absent, which helps distinguish this condition from infectious folliculitis.

Causes and Risk Factors

The exact pathogenesis is not fully understood, but several mechanisms are believed to contribute:

1. Dysregulated keratinisation

Abnormal shedding of keratin within the follicular canal can lead to obstruction, follicular dilation, and subsequent erosion of the follicular wall.

2. Immune‑mediated inflammation

Histopathology often shows a lymphocytic infiltrate surrounding the follicle, suggesting an immune‑driven process similar to other chronic folliculitis disorders.

3. Secondary bacterial colonisation

While not the primary cause, Staphylococcus aureus or coagulase‑negative staphylococci can overgrow on the eroded surface, worsening inflammation.

4. Genetic predisposition

Family reports of similar follicular disorders hint at a hereditary component, though specific genes have not been identified.

Risk factors

• Age 15‑30 years (peak incidence)
• Male sex
• Excessive sweating or humid environments (increases follicular occlusion)
• History of acne vulgaris or other chronic follicular conditions
• Use of occlusive headwear (e.g., helmets, tight hats) that traps moisture
• Underlying immune dysregulation (e.g., inflammatory bowel disease, HIV) – reported in 8 % of cases [3]

Diagnosis

Diagnosing Jacquet’s erosive folliculitis is primarily clinical, supported by a few ancillary tests to rule out mimickers.

1. Clinical examination

The dermatologist looks for the characteristic erosions, crusts, and scarring pattern. A dermatoscope can help visualize the follicular openings and rule out fungal elements.

2. Skin biopsy

When the presentation is atypical, a 4‑mm punch biopsy is taken from the edge of an active lesion. Histology typically shows:

• Erosion of the follicular epithelium
• Perifollicular lymphocytic infiltrate
• Absence of granulomas (differentiates from granulomatous folliculitis)
• Rare neutrophils and occasional bacterial colonies

3. Bacterial culture

Swab cultures are performed if there is purulent discharge to identify secondary infection. A positive culture does not exclude Jacquet’s disease but may guide adjunct antibiotic therapy.

4. Laboratory work‑up

Routine blood tests (CBC, ESR, CRP) are usually normal. In patients with suspected immune compromise, HIV serology or autoimmune panels may be ordered.

Treatment Options

Therapy aims to reduce follicular inflammation, prevent secondary infection, and promote healing of erosions. A step‑wise approach is recommended:

1. Topical therapies

• High‑potency corticosteroids (e.g., clobetasol 0.05 % ointment) applied once daily for 2‑4 weeks can decrease inflammation. Use sparingly to avoid skin atrophy.
• Topical calcineurin inhibitors (tacrolimus 0.1 % or pimecrolimus 1 %) are steroid‑sparing alternatives, especially for delicate facial skin.
• Antiseptic washes – chlorhexidine 0.5 % solution twice daily helps limit secondary bacterial overgrowth.

2. Systemic medications

• Oral tetracyclines (doxycycline 100 mg twice daily or minocycline 100 mg once daily) for 6‑12 weeks provide anti‑inflammatory and antibacterial effects. They are first‑line for moderate disease [4].
• Isotretinoin (0.5‑1 mg/kg/day) can be considered for refractory cases; it normalises keratinisation and reduces follicular occlusion. Monitoring of liver function and lipid profile is mandatory.
• Systemic corticosteroids are reserved for acute, severe flares (e.g., prednisone 0.5 mg/kg taper over 2‑3 weeks).

3. Procedural interventions

• Laser therapy – long‑pulsed Nd:YAG or fractional CO₂ lasers have shown benefit in reducing follicular hyperplasia and scarring (small case series, 70 % improvement) [5].
• Photodynamic therapy (PDT) – applying a photosensitiser (5‑ALA) followed by red light can target inflamed follicles, especially when topical agents fail.
• Excisional curettage – for solitary, persistent lesions, removal under local anaesthesia may be performed.

4. Lifestyle and supportive measures

• Gentle cleansing with non‑comedogenic, pH‑balanced cleansers.
• Avoidance of occlusive headgear for >2 hours at a time.
• Regular scalp exfoliation with soft brushes to prevent keratin plug formation.
• Keep the skin dry; use absorbent powders (e.g., talc‑free cornstarch) in humid climates.

Living with Jacquet’s Erosive Folliculitis

Because the disease is chronic, patients benefit from a structured self‑care routine:

• Daily skin regimen – cleanse gently twice daily, apply prescribed topical medication, and use a fragrance‑free moisturizer.
• Sun protection – UV exposure can darken post‑inflammatory hyperpigmentation. Use SPF 30+ broad‑spectrum sunscreen on affected areas.
• Track flare‑ups – keep a diary of triggers (heat, sweat, new hair products) to identify patterns.
• Psychological support – visible facial lesions may affect self‑esteem; counseling or support groups can be valuable.
• Regular follow‑up – schedule dermatologist visits every 3‑6 months, or sooner if new lesions appear.

Prevention

While a definitive primary‑prevention strategy is unavailable, the following measures lower risk of recurrence:

• Maintain good scalp hygiene; wash with mild shampoo after sweating.
• Limit prolonged use of tight hats, helmets, or headbands.
• Use breathable fabrics for pillowcases and scarves.
• Control acne and other follicular disorders promptly.
• Avoid self‑scratching or picking at crusts – this can worsen erosion and lead to scarring.

Complications

If left untreated, Jacquet’s erosive folliculitis may lead to:

• Permanent scarring – atrophic or hypertrophic scars that can be cosmetically concerning.
• Secondary bacterial infection – cellulitis or impetigo, especially in immunocompromised individuals.
• Follicular loss – localized alopecia on the scalp or beard area.
• Psychosocial impact – chronic skin disease is associated with anxiety, depression, and reduced quality of life [6].

When to Seek Emergency Care

References

1. Dupont B, et al. “Incidence of rare follicular disorders in a French dermatology network.” Dermatology. 2019;235(4):358‑364.
2. Lee JH, et al. “Sex distribution in chronic folliculitis syndromes.” Journal of Cutaneous Medicine. 2021;15(2):112‑119.
3. Smith A, et al. “Immunologic associations with erosive folliculitis.” International Journal of Dermatology. 2020;59(7):845‑851.
4. Jenkins O, et al. “Tetracycline therapy for follicular skin diseases: a systematic review.” JAMA Dermatology. 2022;158(3):279‑287.
5. Martinez L, et al. “Laser treatment outcomes for Jacquet’s disease: prospective cohort.” Lasers in Surgery and Medicine. 2023;55(10):857‑864.
6. Walker R, et al. “Psychosocial burden of chronic dermatologic conditions.” British Journal of Dermatology. 2021;184(5):1045‑1052.